WANG Ming-Yu, ZHANG Li-Hui, ZHOU Hao, ZHAO Yong. Correlation between MTHFR C677T Gene Polymorphism and Cognitive Impairment in Patients with Cerebral Small Vessel Disease[J]. Chinese Journal of Stroke, 2019, 14(11): 1095-1100.
[1] KALARIA R N. The Pathology and Pathophysiologyof Vascular Dementia [J]. Neuropharmacology,2018,134(1):226-239.[2] LIU Y,DONG Y H,LYU P Y,et al. Hypertensioninducedcerebral small vessel disease leading tocognitive impairment [J]. Chin Med J(Engl),2018,131(5):615-619.[3] CHEN X,WANG J,SHAN Y,et al. Cerebral smallvessel disease:neuroimaging markers and clinicalimplication[J]. J Neuro,266(10):2347-2362.[4] RUTTEN-JACOBS L C,TRAYLOR M,ADIBSAMIIP,et al. Association of MTHFR C677Tgenotype with ischemic stroke is confined to cerebralsmall vessel disease subtype[J]. Stroke,2016,47(3):646-651.[5] SZOLNOKI Z,SZANISZLO I,SZEKERES M,etal. Evaluation of the MTHFR A1298C variant inleukoaraiosis[J]. J Mol Neurosci,2012,46(3):492-496.[6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国脑小血管病诊治共识[J]. 中华神经科杂志,2015,48(10):838-844.[7] LIAKAKIS G. Biochemical diagnosis of vascularcognitive impairment associated with subcorticalsmall vessel disease[J]. Hell J Nucl Med,2019,22(1-4):187-193.[8] WARDLAW J M,SMITH C,DICHGANS M,et al.Mechanisms of sporadic cerebral small vessel disease:insights from neuroimaging[J]. Lancet Neurol,2013,12(5):483-497.[9] PANTONI L. Cerebral small vessel disease:frompathogenesis and clinical characteristics totherapeutic challenges[J]. Lancet Neurol,2010,9(7):689-701.[10] JACKSON C A,HUTCHISON A,DENNIS MS,et al. Differing risk factor profiles of ischemicstroke subtypes:evidence for a distinct lacunararteriopathy?[J]. Stroke,2010,41(4):624-629.[11] MA Y,ZHAO X,ZHANG W,et al. Homocysteineand ischemic stroke subtype:a relationship study inChinese patients[J]. Neurol Res,2010,32(6):636-641.[12] LIU J,JIN X,LIU K J,et al. Matrixmetalloproteinase-2mediated occludin degradationand caveolin-1-mediated claudin-5 redistributioncontribute to blood-brain barrier damage in earlyischemic stroke stage[J]. J Neurosci,2012,32(9):3044-3057.[13] TIAN X,ZHAO L,SONG X,et al. HSP27 inhibitshomocysteine-induced endothelial apoptosis bymodulation of ROS production and mitochondrialcaspase-dependent apoptotic pathway[J/OL].Biomed Res Intl,2016:4847874. https://doi.org/10.1155/2016/4847874.[14] LAI W K,KAN M Y. Homocysteine-inducedendothelial dysfunction[J]. Ann Nutr Metab,2015,67(1):1-12.
[15] BIESBROEK J M,WEAVER N A,BIESSELS GJ. Lesion location and cognitive impact of cerebralsmall vessel disease[J]. Clin Sci(Lond),2017,131(8):715-728.[16] LU D,LI P,ZHOU Y,et al. Association betweenserum non-highdensity lipoprotein cholesterol andcognitive impairment in patients with acute ischemicstroke[J]. BMC Neurol,2016,16(1):154-163.[17] DUFOUIL C,ALPÉROVITCH A,DUCROS V,etal. Homocysteine,white matter hyperintensities,and cognition in healthy elderly people[J]. AnnNeurol,2003,53(2):214-221.[18] VAN DEN KOMMER T N,DIK M G,COMIJS HC,et al. Homocysteine and inflammation:predictorsof cognitive decline in older persons?[J]. NeurobiolAging,2010,31(10):1700-1709.[19] SHANKLE W R,HARA J,BARRENTINE L W,etal. CerefolinNAC therapy of hyperhomocysteinemiadelays cortical and white matter atrophy inAlzheimer's disease and cerebrovascular disease[J]. JAlzheimers Dis,2016,54(3):1073-1084.[20] MOORE E,MANDER A,AMES D,et al.Cognitive impairment and vitamin B12:a review[J].Int Psychogeriatr,2012,24(4):541-556.[21] LIEW S C,GUPTA E D. Methylenetetrahydrofolatereductase(MTHFR)C677T polymorphism:epidemiology,metabolism and theassociateddiseases[J]. Eur J Med Genet,2015,58(1):1-10.[22] LI A,SHI Y,XU L,et al. A possible synergisticeffect of MTHFR C677T polymorphism onhomocysteine level variations increased risk forischemic stroke[J]. Medicine,2017,96(51):51-56.[23] CHOI B O,KIM N K,KIM S H,et al. HomozygousC677T mutation in the MTHFR gene as anindependent risk factor for multiple small-arteryocclusions[J]. Thromb Res,2003,11(1-2):39-44.